Literature DB >> 31954486

Milestones in the pathogenesis and management of primary liver cancer.

Jean-Charles Nault1, Ann-Lii Cheng2, Bruno Sangro3, Josep M Llovet4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31954486     DOI： 10.1016/j.jhep.2019.11.006

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  13 in total

1.  Correlation analysis of intestinal flora and immune function in patients with primary hepatocellular carcinoma.

Authors:  Simiao Zhang; Lixia Hou; Qingyu Sun
Journal:  J Gastrointest Oncol       Date:  2022-06

Review 2.  A review of cutting-edge therapies for hepatocellular carcinoma (HCC): Perspectives from patents.

Authors:  Yan Gao; Liyang Lyu; Ye Feng; Fei Li; Yuanjia Hu
Journal:  Int J Med Sci       Date:  2021-06-18       Impact factor: 3.738

Review 3.  The immunological and metabolic landscape in primary and metastatic liver cancer.

Authors:  Xin Li; Pierluigi Ramadori; Dominik Pfister; Marco Seehawer; Lars Zender; Mathias Heikenwalder
Journal:  Nat Rev Cancer       Date:  2021-07-29       Impact factor: 60.716

Review 4.  Organoids for the Study of Liver Cancer.

Authors:  Haichuan Wang; Diego F Calvisi; Xin Chen
Journal:  Semin Liver Dis       Date:  2021-02-09       Impact factor: 6.115

Review 5.  Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.

Authors:  Josep M Llovet; Thierry De Baere; Laura Kulik; Philipp K Haber; Tim F Greten; Tim Meyer; Riccardo Lencioni
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-01-28       Impact factor: 46.802

6.  Circular RNA hsa_circ_0013958 Functions as an Oncogenic Gene Through Modulating miR-532-3p/WEE1 Axis in Hepatocellular Carcinoma.

Authors:  Tao Ma; Yue Ma; Yongjun Du; Zhongheng Wei; Jianchu Wang; Yufu Jun; Fenqiang Xiao
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

7.  The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma.

Authors:  Cunjie Chang; Muthukumar Rajasekaran; Yiting Qiao; Heng Dong; Yu Wang; Hongping Xia; Amudha Deivasigamani; Minjie Wu; Karthik Sekar; Hengjun Gao; Mengqing Sun; Yuqin Niu; Qian Li; Lin Tao; Zhen Yan; Menglan Wang; Shasha Chen; Shujuan Zhao; Dajing Chen; Lina Li; Fan Yang; Haojin Gao; Baodong Chen; Ling Su; Liang Xu; Ye Chen; Veerabrahma Pratap Seshachalam; Gongxing Chen; Jayantha Gunaratne; Wanjin Hong; Junping Shi; Gongying Chen; David S Grierson; Benoit Chabot; Tian Xie; Kam Man Hui; Jianxiang Chen
Journal:  Nat Commun       Date:  2022-03-16       Impact factor: 17.694

8.  Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers.

Authors:  Maya S Krishnan; Anand Rajan Kd; Jangho Park; Vinodhini Arjunan; Fernando Jose Garcia Marques; Abel Bermudez; Olivia A Girvan; Nam S Hoang; Jun Yin; Mindie H Nguyen; Nishita Kothary; Sharon Pitteri; Dean W Felsher; Renumathy Dhanasekaran
Journal:  Hepatology       Date:  2021-05-08       Impact factor: 17.298

Review 9.  Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases.

Authors:  Eirini I Rigopoulou; George N Dalekos
Journal:  Cancers (Basel)       Date:  2021-03-01       Impact factor: 6.639

10.  Clinical Effect of Iodine-125 Seed Implantation in Patients with Primary Liver Cancer and Its Effect on Th1/Th2 Cells in Peripheral Blood.

Authors:  Xiaoyan Chen; Fan Zhu; Bin Wang; Yu Zhou; Hao Xiong; Tao Fan; Wenjie Ke
Journal:  J Oncol       Date:  2021-07-29       Impact factor: 4.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.